{
    "eid": "2-s2.0-84952907302",
    "title": "NUDT15 c.415C>T increases risk of 6-mercaptopurine induced myelosuppression during maintenance therapy in children with acute lymphoblastic leukemia",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Hematology",
            "@code": "2720"
        }
    ],
    "keywords": [
        "Acute lymphoblastic leukemia",
        "Myelosuppression",
        "NUDT15",
        "Pharmacogenetics"
    ],
    "authors": [
        "Kanhatai Chiengthong"
    ],
    "citedby-count": 76,
    "ref-count": 15,
    "ref-list": [
        "Children's oncology Group's 2013 blueprint for research: Acute lymphoblastic leukemia",
        "THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIA",
        "Chemotherapy of acute lymphocytic leukemia of childhood",
        "Mercaptopurine/methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: Clinical facts and fiction",
        "Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia",
        "Implementation of TPMT testing",
        "Molecular analysis of thiopurine s-methyltransferase alleles in south-east asian populations",
        "Thiopurine S-methyltransferase polymorphism in the Thai population",
        "Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand",
        "Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine",
        "The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children",
        "A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia",
        "Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia",
        "Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia",
        "Outcome of acute lymphoblastic leukemia treatment using national protocols at the Queen Sirikit National Institute of Child Health"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}